Literature DB >> 11203461

Monoamine oxidase inhibitors in rheumatoid arthritis-anti-tumor necrosis factor?

E L Altschuler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11203461     DOI： 10.1016/s0192-0561(00)00047-3

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN： 0192-0561


× No keyword cloud information.
  4 in total

1.  Lipopolysaccharide-induced epithelial monoamine oxidase mediates alveolar bone loss in a rat chronic wound model.

Authors:  Daisuke Ekuni; James D Firth; Tarun Nayer; Takaaki Tomofuji; Toshihiro Sanbe; Koichiro Irie; Tatsuo Yamamoto; Takashi Oka; Zhenzi Liu; Juergen Vielkind; Edward E Putnins
Journal:  Am J Pathol       Date:  2009-09-24       Impact factor: 4.307

2.  Paeonol suppresses solar ultraviolet-induced skin inflammation by targeting T-LAK cell-originated protein kinase.

Authors:  Peipei Xue; Yong Wang; Fanfan Zeng; Ruijuan Xiu; Jingwen Chen; Jinguang Guo; Ping Yuan; Lin Liu; Juanjuan Xiao; Hui Lu; Dan Wu; Huaxiong Pan; Mingmin Lu; Feng Zhu; Fei Shi; Qiuhong Duan
Journal:  Oncotarget       Date:  2017-04-18

3.  Inhibiting peripheral and central MAO-B ameliorates joint inflammation and cognitive impairment in rheumatoid arthritis.

Authors:  Woojin Won; Hyun-Ji Choi; Ji-Young Yoo; Daeun Kim; Tai Young Kim; YeonHa Ju; Ki Duk Park; Hyunbeom Lee; Sang Youn Jung; C Justin Lee
Journal:  Exp Mol Med       Date:  2022-08-18       Impact factor: 12.153

4.  Immunomodulation Mechanism of Antidepressants: Interactions between Serotonin/Norepinephrine Balance and Th1/Th2 Balance.

Authors:  Matteo Martino; Giulio Rocchi; Andrea Escelsior; Michele Fornaro
Journal:  Curr Neuropharmacol       Date:  2012-06       Impact factor: 7.363
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.